Skip to main content
The EPA approved the registration and use of a renewable gasoline blendstock developed by Vertimass LLC and Oak Ridge National Laboratory that can significantly reduce vehicle emissions when added to conventional fuels. Credit: Adam Malin/ORNL, U.S. Dept. of Energy

The U.S. Environmental Protection Agency has approved the registration and use of a renewable gasoline blendstock developed by Vertimass LLC and ORNL that can significantly reduce the emissions profile of vehicles when added to conventional fuels. 

The transportation and industrial sectors together account for more than 50% of the country’s carbon footprint. Defossilization could help reduce new emissions from these and other difficult-to-electrify segments of the U.S. economy.

Scientists at Oak Ridge National Laboratory and six other Department of Energy national laboratories have developed a United States-based perspective for achieving net-zero carbon emissions. 

map

Three ORNL intellectual property projects with industry partners have advanced in DOE's Office of Technology Transitions Making Advanced Technology Commercialization Harmonized, or Lab MATCH, prize, which encourages entrepreneurs to find actionable pathways that bring lab-developed intellectual property to market. 

ORNL engineer Canan Karakaya uses computational modeling to design and improve chemical reactors and how they are operated to convert methane, carbon dioxide, ammonia or ethanol into higher-value chemicals or energy-dense fuels. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Canan Karakaya, a R&D Staff member in the Chemical Process Scale-Up group at ORNL, was inspired to become a chemical engineer after she experienced a magical transformation that turned ammonia gas into ammonium nitrate, turning a liquid into white flakes gently floating through the air. 

Representatives from several local partners attended a ribbon-cutting for the new SkyNano facility in Louisville, Tennesse. Front row, from left to right are Deborah Crawford, vice chancellor for research at the University of Tennessee, Knoxville; Tom Rogers, president and chief executive officer of the UT Research Park; Lindsey Cox, CEO of LaunchTN; Cary Pint, SkyNano co-founder and chief technology officer; Susan Hubbard, ORNL deputy for science and technology; Anna Douglas, SkyNano co-founder and CEO; Ch

SkyNano, an Innovation Crossroads alumnus, held a ribbon-cutting for their new facility. SkyNano exemplifies using DOE resources to build a successful clean energy company, making valuable carbon nanotubes from waste CO2. 

ORNL

Two different teams that included Oak Ridge National Laboratory employees were honored Feb. 20 with Secretary’s Honor Achievement Awards from the Department of Energy. This is DOE's highest form of employee recognition. 

Chelsea Chen, polymer physicist at ORNL, stands in front of an eight-channel potentiostat and temperature chamber used for battery and electrochemical testing. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy

Chelsea Chen, a polymer physicist at ORNL, is studying ion transport in solid electrolytes that could help electric vehicle battery charges last longer.

In a win for chemistry, inventors at ORNL have designed a closed-loop path for synthesizing an exceptionally tough carbon-fiber-reinforced polymer, or CFRP, and later recovering all of its starting materials.

In a win for chemistry, inventors at ORNL have designed a closed-loop path for synthesizing an exceptionally tough carbon-fiber-reinforced polymer, or CFRP, and later recovering all of its starting materials.

ORNL's Kyle Gluesenkamp received the FLC Outstanding Researcher Award.

Four ORNL teams and one researcher were recognized for excellence in technology transfer and technology transfer innovation. 
 

ORNL’s Tomás Rush examines a culture as part of his research into the plant-fungus relationship that can help or hinder ecosystem health. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy

New computational framework speeds discovery of fungal metabolites, key to plant health and used in drug therapies and for other uses.